Proposing Chemotherapy For Healthy Women?
In a perversion of modern day medicine, the U.S. Preventive Services Task Force (USPSTF) has issued recommendations (that have been promoted by the New York Times) that urge healthy women to get prescribed chemotherapy drugs as a preventitive, to decrease their risk of developing breast cancer. In this environment, where dangerous drugs are being prescribed without much cause, it is extremely important for breast cancer patients or those who feel they are at risk to understand that alternative breast cancer treatment options exist that will not put their life in jeopardy.
To make matters worse, there is no evidence whatsoever that these drugs can actually have a preventitive effect. All this while there are plenty of alternative breast cancer treatments that treat the whole body in a way that allows patients to survive on their own terms.
One of the core principles of treatment at Hope4Cancer is the use of Non-Toxic therapies. You can find out more about Non-Toxic Cancer Therapies by clicking here.
The USPSTF has recommended that healthy women who have either a personal or family history of breast cancer, or who are considered to be high risk, should take either of the two drugs for a minimum period of five years. They are also encouraging doctors to begin actively prescribing these drugs to healthy female patients in the age range of 40-70.
Raloxifene is a selective estrogen receptor modulator in that it works like estrogen slowing down the bone thinning process of osteoporosis, and as an anti-estrogen by blocking access of estrogen to the estrogen-receptor of breast cancer cells. Side Effects of Raloxifene are similar to those of Tamoxifen. WebMD cautions people to watch for symptoms of pulmonary embolism (breathing trouble), chest pain, fast heart rate, blood clots symptoms (e.g. swelling, warmth, pain and tenderness, redness).
According to a number of studies, tamoxifen can lower the risk of recurrence by about 50 percent. Many women tell us about their fight in sustaining through the depression cycles they go through while on tamoxifen. Many women quit within a couple of years because of the frustration, discomfort, problems with sexual function, even if you do not consider the potential of major side effects.
A recent study published in the prestigious journal, Lancet, finds that taking Tamoxifen over 10 years can be more effective by decreasing the risk of recurrence by an additional 3.7%. This was accompanied with a slight rise in the risk of endometrial cancer. For women in their childbearing age, they might as well say goodbye to their chances of having children if they want them.
The group estimates that for every 1000 healthy women who take either of the two drugs, roughly eight of them will avoid developing breast cancer in the next 5 years. To justify those odds, 1000 women would need to be prescribed unnecessary medication and have to face potentially life-threatening side effects and loss in quality of life.
The fact is that the vast majority of people who are considered to be “at risk” are really not at risk in the sense that they will never develop breast cancer. The USPSTF admits in their report that most breast cancer cases occur in women who were never identified as being “high risk”. Mind boggling deductive reasoning indeed!
The end game: following the non-existent logic of the entire proposal, it is clear that the only impact of these changes will be to increase sales of tamoxifen and raloxifene without making a dent on cancer recurrence or incidence. It will also help the antidepressant drug industry as well.
The question is, what can patients do in the face of strong pressure from their medical community, peer group, family and friends? People need to know that alternative breast cancer treatment options exist. Acquiring knowledge and building confidence in alternative methods is a good start.
Hope4Cancer Treatment Centers in Mexico treats patients as a whole person capable of fighting the cancer challenge. The focus is on building the immune system and eliminating toxins, instead of introducing stop gap, long term, toxic drug interventions that cause harm to the body without building up its intrinsic ability to beat cancer.